Biological catalysis regulated by cucurbit[7]uril molecular containers

We report the synthesis of two-faced inhibitors 1-5 that contain both enzyme inhibitor and cucurbit[n]uril binding domains. The enzyme binding domains of 1-5 bind to the active sites of bovine carbonic anhydrase (BCA) or acetylcholinesterase (AChE) and inhibit their catalytic activities. Addition of CB[7] to BCA*1 and BCA*2 results in the transient formation of the BCA*1*CB[7] and BCA*2*CB[7] ternary complexes that undergo rapid dissociation to form free catalytically active BCA along with CB[7]*1 and CB[7]*2. The on-off cycle can be performed repetitively by the sequential addition of competitive guest 8 and CB[7]. The detailed origins of this on-off switching of the catalytic activity of BCA is delineated by the combined inference of UV/vis catalytic assays, fluorescence displacement assays, (1)H NMR, along with measurement of the fundamental values of K(a), k(on), and k(off) for the various complexes involved. In contrast, addition of CB[7] to AChE*4(4) and AChE*5(4) results in the formation of thermodynamically stable ternary complexes AChE*4(4)*CB[7](4) and AChE*5(4)*CB[7](4) that are catalytically inactive. We highlight some of the advantages and disadvantages of the strategy, based on the direct competition between two receptors (e.g., enzyme and CB[7]) for a common inhibitor, used in this paper to control enzyme catalytic activity compared to the strategy employed by Nature involving the binding of an allosteric small molecule remote from the enzyme active site.

Complex interactions of pillar[5]arene with paraquats and bis(pyridinium) derivatives

The complexation behavior of a series of paraquats (G1.2PF(6)-G5.2PF(6)) and bis(pyridinium) derivatives (G6.2PF(6)-G14.2PF(6)) with pillar[5]arene (P5A) host has been comprehensively investigated by (1)H NMR, ESI mass and UV-vis absorption spectroscopy. It is found that P5A forms 2 : 1 external complexes with N,N'-dialkyl-4,4'-bipyridiniums (G1-G4.2PF(6)); while it forms 1 : 1 pseudorotaxane-type inclusion complexes with methylene [-(CH(2))(n)-] linked bis(pyridinium) derivatives possessing appropriate chain lengths (n = 3-6, G7-G10.2PF(6)). Host-guest association constants in dimethyl sulfoxide (DMSO) were determined, indicating G7-G10.2PF(6) axles form stable [2]pseudorotaxanes with P5A wheel in this very high polarity solvent and 1,4-bis(pyridinium)butane (G8.2PF(6)) was the most suitable axle unit. Meanwhile, the nature of the substituents attached to 1,4-bis(pyridinium)butane dramatically affects the molecular recognition behavior. The introduction of pyridyls (G13.2PF(6)) increases not only the K(a) value (4.5 x 10(2) --> 7.4 x 10(2) M(-1)), but also the charge transfer (CT) absorption (colorless --> yellow). Furthermore, the solvent effects have also been investigated, showing they significantly influence the association strength during the course of host-guest complexation. Particularly, the K(a) value of P5A-G13.2PF(6) in 1 : 1 (v:v) acetone-d(6)/DMSO-d(6) is enhanced by a factor of 7.3 compared with pure DMSO-d6 (7.4 x 10(2) --> 5.4 x 10(3) M(-1)).

Host-guest complexations of local anaesthetics by cucurbit[7]uril in aqueous solution

The cucurbit[7]uril (CB[7]) host molecule forms very stable host-guest complexes with the local anaesthetics procaine (K(CB[7]) = (3.5 +/- 0.7) x 10(4) dm(3) mol(-1)), tetracaine (K(CB[7]) = (1.5 +/- 0.4) x 10(4) dm(3) mol(-1)), procainamide (K(CB[7]) = (7.8 +/- 1.6) x 10(4) dm(3) mol(-1)), dibucaine (K(CB[7]) = (1.8 +/- 0.4) x 10(5) dm(3) mol(-1)) and prilocaine (K(CB[7]) = (2.6 +/- 0.6) x 10(4) dm(3) mol(-1)) in aqueous solution (pD = 4.75). The stability constants are 2-3 orders of magnitude greater than the values reported for binding by the comparably sized beta-cyclodextrin host molecule. The inclusion by CB[7] raises the first pK(a) values of the anaesthetics by 0.5-1.9 pK units, as the protonated forms are bound more strongly in acidic solution. The complexation-induced chemical shift changes in the guest proton resonances provide an indication of the site(s) of binding and the effects of protonation on the location of the binding sites.